NCT07050810
Thera-Clean® Microbubbles System in Patients With Skin Diseases
Enrolling by Invitation
EARLY_PHASE1Ages 2+InterventionalTreatmentNorthwestern UniversityInvestigator-initiated
~20 participants
Updated 2026-02-03 on ClinicalTrials.gov
What's tested:TheraClean
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Improvement of skin condition between baseline to Week 4 and baseline to Week 8 using Thera-Clean® microbubble bathing therapy as assessed by the Investigator Global Assessment (IGA).
Measured over 8 weeks
Conditions
Where it's being run
1 sites across 1 statesIllinois1
Study leadership
- Amy Paller, MD · PRINCIPAL_INVESTIGATOR · Northwestern University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients 2 years of age or above with psoriasis, atopic dermatitis/eczema, epidermolysis bullosa, or ichthyosis
Skin conditions to be stable for at least the previous 4-week period (patients will continue to use their typical skin treatment regimen throughout the study)
Exclusion
Patients with unstable skin conditions
Patients not willing to comply with the study requirements for bathing at home
Patients younger than 2 years of age
What this trial measures
- Improvement of skin condition between baseline to Week 4 and baseline to Week 8 using Thera-Clean® microbubble bathing therapy as assessed by the Investigator Global Assessment (IGA).8 weeks
IGA will be assessed on a 4-point scale: clear; almost clear; mild; moderate; severe.